Company Second Sight Medical Products

Equities

EYES

US81362J3086

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
1.73 USD -3.89% Intraday chart for Second Sight Medical Products -5.98% -24.12%

Business Summary

Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing implantable visual prosthetics devices that restore vision to blind individuals. The Company manufactures neuromodulation devices for blindness and engaged in developing new technologies to treat sight-impaired individuals. Its approved product, the Argus II Retinal Prosthesis System (Argus II), treats outer retinal degenerations, such as retinitis pigmentosa (RP). It is engaged in developing the Orion Visual Cortical Prosthesis System (Orion), an implanted cortical stimulation device, which provides artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease and eye injury. Orion works by converting video images captured by a miniature camera housed in a user's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes.

Number of employees: 15

Company contact information

Second Sight Medical Products, Inc.

13170 Telfair Avenue

91342, Sylmar

+818 833 5000

https://www.vivani.com
address Second Sight Medical Products(EYES)

Sector

This company's sector is not yet available
  1. Stock Market
  2. Equities
  3. EYES Stock
  4. Company Second Sight Medical Products